Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2Wilms Tumor 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Pheochromocytoma 1Paraganglioma 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Hepatoblastoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 14Etoposide 12Temozolomide 10Carboplatin 9Granulocyte Colony-Stimulating Factor 8Filgrastim 8Vincristine 7etoposide phosphate 6X-Rays 6Thiotepa 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cisplatin 6Topotecan 5Specimen Handling 5Radiotherapy 5Nuclear Medicine Department, Hospital 5Methotrexate 5fludarabine 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mesna 4Melphalan 4Biopsy 4palbociclib 3Sirolimus 3Irinotecan 3Ifosfamide 3Busulfan 3Automobiles 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × talazoparib × CNS × Clear all
NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡